Current Cancer Drug Targets
Title:Preface
Volume: 18 Issue: 1
Author(s): Ruiwen Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Zhang Ruiwen , Preface, Current Cancer Drug Targets 2018; 18 (1) . https://dx.doi.org/10.2174/156800961801171208144050
DOI https://dx.doi.org/10.2174/156800961801171208144050 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Developments of Three-Dimensional Paper-Based Electrochemical Devices for Cancer Cell Detection and Anticancer Drug Screening
Current Pharmaceutical Biotechnology Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Current Cancer Drug Targets Plasmid DNA Gene Therapy by Electroporation: Principles and Recent Advances
Current Gene Therapy Current Concepts on the Genetics and Pharmacogenetics of Inflammatory Bowel Disease: Do they Help in Clinical Management?
Current Genomics Genetics and Epigenetics of Lung Cancer: Mechanisms and Future Perspectives
Current Cancer Therapy Reviews Trends in Nanotechnology Patents Applied to the Health Sector
Recent Patents on Nanotechnology Surface Modified Nanoparticulate Carrier Constructs for Oral Mucosal Vaccine Delivery
Current Drug Delivery Application of Alphaviral Vectors for Immunomodulation in Cancer Therapy
Current Pharmaceutical Design Base Excision Repair, the Redox Environment and Therapeutic Implications
Current Molecular Pharmacology Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders
Current Pharmaceutical Design Role of Cytochrome P450 in Prostate Cancer and its Therapy
Current Enzyme Inhibition Acknowledgements to Reviewers
Current Cancer Drug Targets Development of Decision Tree Models for Substrates, Inhibitors, and Inducers of P-Glycoprotein
Current Drug Metabolism Metformin: A Rising Star to Fight the Epithelial Mesenchymal Transition in Oncology
Anti-Cancer Agents in Medicinal Chemistry Integration of DNA Methylation Data and Gene Expression Data for Prostate Adenocarcinoma: A Proof of Concept
Current Bioinformatics Viral Mediated Gene Therapy for the Management of Metastatic Thyroid Carcinoma
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Ghrelin: New Insight to Mechanisms and Treatment of Postoperative Gastric Ileus
Current Pharmaceutical Design Anticancer Compounds as Leishmanicidal Drugs: Challenges in Chemotherapy and Future Perspectives
Current Medicinal Chemistry EGF-R Small Inhibitors and Anti-EGF-R Antibodies: Advantages and Limits of a New Avenue in Anticancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Molecular Aspects of Intestinal Radiation-Induced Fibrosis
Current Molecular Medicine